Figures
The captions for Figs 5 and 6 are incorrectly switched. The publisher apologizes for the error. The caption that appears under Fig 5 should be under Fig 6, and the caption that appears under Fig 6 should be under Fig 5. The figure images appear in the correct order.
(A) Dupilumab Fab (HC in green and LC in cyan) complexed with human IL4R extracellular domain (in magenta and glycosylation in yellow sticks, PDB: 6WGL), (B) human IL17 dimer (magenta and pink) complexed with Secukinumab Fabs (HCs in green and LCs in cyan, PDB: 6WIR).
Column fractions from size exclusion chromatography were used directly in a vapor diffusion crystallization experiment in 4 conditions. (A) shows the chromatogram. (B) shows the images of every crystallization drop at day 9 (C) shows the score assigned to each, where anything crystalline is scored at 90 or higher.
Reference
- 1. Lieu R, Antonysamy S, Druzina Z, Ho C, Kang NR, Pustilnik A, et al. (2020) Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing. PLoS ONE 15(9): e0232311. https://doi.org/10.1371/journal.pone.0232311 pmid:32915778
Citation: The PLOS ONE Staff (2021) Correction: Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing. PLoS ONE 16(10): e0258412. https://doi.org/10.1371/journal.pone.0258412
Published: October 5, 2021
Copyright: © 2021 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.